1. Denton N, Molloy M, Charleston S, et al. Data silos are undermining drug development and failing rare disease patients. Orphanet J Rare Dis. 2021;16:161. https://doi.org/10.1186/s13023-021-01806-4).
2. Directive 2001/20/EC of the European Parliament and the Council of 4 Apr 2001 on the approximation of laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Off J Eur Commun. 2001, L121.
3. Regulation (EU) No 536/2014 of the European Parliament and the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (Text with EEA relevance). Off J Eur Commun. 2014. L 158/1.
4. Department of Health & Social Care. The UK Rare Diseases Framework. 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/950651/the-UK-rare-diseases-framework.pdf.
5. Dahabreh IJ, Hayward R, Kent DM. Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence. Int J Epidemiol. 2016;45(6):2184–93.